Quick Answer: In Australia, cosmetic and therapeutic classifications depend on the actual product and its use and representations, not simply on its retail category. A cosmetic brief and a therapeutic brief can lead to different regulatory workstreams. Review composition, instructions, complete claims and applicable exclusions together. Brand owners should obtain product-specific advice before treating a boundary product as an ordinary cosmetic.
MOOYAM editorial content. Last reviewed: 13 October 2026. Cover: AI-generated editorial illustration.
What is the practical difference for a beauty brand?
The distinction changes how the launch should be planned. A brand developing a conventional cosmetic needs an Australian cosmetic-compliance review. A product with a therapeutic purpose or representation raises an additional classification and pathway question. Neither decision should be made solely from the name of the product category in a supplier catalogue.
This comparison focuses on the product-development brief and evidence handover. It does not classify a particular formula. For a broader launch sequence, use our guide to selling cosmetics in Australia.
What do the official definitions tell us?
Section 9 of the Industrial Chemicals Act 2019 (official PDF) defines a cosmetic by reference to contact with the body and specified cosmetic purposes, while excluding therapeutic goods. Section 3 of the Therapeutic Goods Act 1989 (official PDF) addresses therapeutic goods and therapeutic use, including representations and relevant exclusions. Read the applicable instruments as well as the basic definitions.
| Question | Cosmetic-development brief | Therapeutic classification concern |
|---|---|---|
| What is the proposed purpose? | Describe the cosmetic function precisely | Identify any therapeutic purpose requiring review |
| What does the copy communicate? | List all cosmetic representations | Review treatment-related or physiological statements |
| How is the product used? | State the actual application and instructions | Assess whether use changes the regulatory question |
| What evidence is available? | Match evidence to the proposed product and claims | Ask what the applicable pathway requires |
| Are exclusions relevant? | Do not assume exclusion from a product name | Check the specific conditions before relying on an exclusion |
Why can the same-looking bottle raise a different question?
A bottle is a packaging format, not a regulatory category. Two products can look similar while having different intended purposes, formulas, directions or advertising. Conversely, a change to the copy can require reconsideration even when the physical pack and formula remain unchanged. Classification review needs the complete presentation.
During development, ask the marketing team to explain the intended customer outcome in plain language. Then separate the proposed cosmetic statements from any statements that need further classification advice. Do not use a euphemism to hide an unresolved therapeutic intention; the reviewer needs an accurate description of the planned product.
How should claims be reviewed across sales channels?
Build one controlled claims inventory covering the carton, container, website, marketplace listing, distributor brochure and any creator briefing supplied by the brand. The point is consistency, not adding claims to every surface. A pack review can lose its value if a distributor later publishes stronger, unreviewed wording.
Record the exact proposed language rather than a summary such as “standard skincare claims.” Preserve the reviewer-approved version and explain any conditions to the people preparing advertisements. Where a statement is rejected or unresolved, mark it clearly so it is not accidentally restored during a design revision.
For international brands, translation is another change-control point. Review complete translated sentences and their context. A translated phrase that communicates a stronger intended use should not be accepted merely because the English artwork passed an earlier review.
What belongs in the classification review pack?
Provide the controlled formula, relevant composition information, intended use, instructions and complete retail presentation. Add supporting evidence with a clear description of what it covers. Name the proposed importing and supplying parties. The reviewer should be able to connect all documents to one product version.
If formula information is confidential, agree a disclosure route. Do not replace it with an invented concentration or an incomplete hero-ingredient list. A business decision to protect know-how should be addressed contractually and operationally, while still allowing the required review to receive sufficient information.
Keep a version index. For each file, list the product identifier, revision, issuing party and date received. An old label attached to a new formula can otherwise make a review appear complete when the documents actually describe different products.
Who provides what: manufacturer versus brand?
| Manufacturer | Brand / Australian supply team | Reviewer |
|---|---|---|
| Controlled formula and agreed technical records | Actual purpose, claims and sales presentation | Assess the product-specific classification question |
| Packaging specifications and relevant quality evidence | Complete artwork and channel copy | Identify additional information and conditions |
| Notice of agreed formula or production changes | Route marketing and supply changes for reconsideration | Reassess affected conclusions within the agreed scope |
This matrix describes project coordination, not a transfer of statutory duties. Define actual legal roles separately. A manufacturer may support a technical review without being the Australian importer, sponsor or legal adviser. The brand should identify who administers each applicable local requirement.
What changes after the classification decision?
Translate the conclusion into a release checklist. Record the product version assessed, the relevant framework, unresolved workstreams and any restrictions on the proposed presentation. Do not call the whole project “approved” if only one part of the review has been completed.
A cosmetic conclusion does not remove every other compliance task. Ingredient-introduction, retail information, safety and claims workstreams still need appropriate review. A therapeutic conclusion requires the team to identify the correct pathway rather than treating a cosmetic factory’s standard document bundle as sufficient.
For sourcing and technical-documentation considerations, see manufacturing for Australian beauty brands. Keep commercial sourcing decisions distinct from the legal classification conclusion.
Common briefing mistakes
- Classifying by category name: a marketplace shelf label is not a product-specific decision.
- Reviewing only one panel: include the complete claims and instructions.
- Using a previous product’s conclusion: verify that it covers this formula and presentation.
- Treating “natural” as a regulatory answer: it does not resolve the intended-use question.
- Leaving changes informal: route altered copy, formula and supply arrangements through the review process.
FAQ
Is every skincare product a cosmetic?
No. Assess its actual purpose, composition, use, representations and applicable exclusions.
Can claims change the classification question?
Yes. Representations are relevant under the therapeutic-goods definition. Review the complete presentation.
Can I rely on a competitor’s classification?
Not as a substitute for reviewing your own product. Similar appearance does not establish identical circumstances.
Who should prepare the claims sheet?
The brand should collect the proposed wording from every relevant channel and coordinate the qualified review.
Does a cosmetic conclusion finish the launch?
No. Close the other applicable Australian compliance workstreams before release.
Build a clear OEM/ODM brief
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Explore our OEM/ODM service or contact us to discuss formula, packaging and documentation requirements.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.